![Gordon H. Busenbark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gordon H. Busenbark
Directeur Financier/CFO chez
Cianna Medical, Inc.
Profil
Gordon H.
Busenbark is currently the Chief Financial Officer at Cianna Medical, Inc. He previously held positions as Director at Nventa Biopharmaceuticals Corp.
and Akela Pharma, Inc. He was also the Vice President-Global Quality at Baxter Healthcare Corp.
from 1998 to 2003 and the Chief Financial Officer at Encysive Pharmaceuticals, Inc. from 2007 to 2009.
Additionally, he served as the Chief Financial Officer at Xytis, Inc., Inspiration Biopharmaceuticals, Inc., and Immuno AG.
Mr. Busenbark received his undergraduate and MBA degrees from the University of Utah in 1979.
Postes actifs de Gordon H. Busenbark
| Sociétés | Poste | Début |
|---|---|---|
Cianna Medical, Inc.
 Cianna Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and designs medical products for treatment of early-stage breast cancer in women | Directeur Financier/CFO | - |
Anciens postes connus de Gordon H. Busenbark
| Sociétés | Poste | Fin |
|---|---|---|
Xytis, Inc.
 Xytis, Inc. BiotechnologyHealth Technology Develops & discovers CNS drug candidates | Directeur Financier/CFO | 01/10/2009 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Directeur Financier/CFO | 01/10/2009 |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Directeur/Membre du Conseil | 22/05/2009 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | 01/01/2003 |
Immuno AG | Directeur Financier/CFO | - |
Formation de Gordon H. Busenbark
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Health Technology |
Xytis, Inc.
Xytis, Inc. BiotechnologyHealth Technology Develops & discovers CNS drug candidates | Health Technology |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Health Technology |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akela Pharma, Inc.
 Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Health Technology |
Cianna Medical, Inc.
Cianna Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and designs medical products for treatment of early-stage breast cancer in women | Health Technology |
Immuno AG |
Choisissez Zonebourse 
